---
schema_version: "secwatch.filing_event.v1"
accession: "0001680367-23-000049"
form_type: "8-K"
ticker: "STTK"
cik: "0001680367"
company_name: "Shattuck Labs, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:07:27.277535+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Shattuck Labs Q2 net loss $21.3M ($0.50/sh); cash $117.2M; SL-172154 trials advancing

## Summary
- Cash and investments $117.2M at June 30, 2023, down from $214.2M a year earlier; runway through end of 2024.
- Net loss of $21.3M ($0.50 per share) for Q2 2023 vs. $27.4M ($0.65) in Q2 2022; R&D spend decreased to $18.2M.
- Phase 1A PROC monotherapy data presented at ASCO 2023; 3 mg/kg dose selected for combination cohorts.
- Enrollment completed in dose-escalation part of Phase 1A/B for SL-172154 in AML/HR-MDS; initial combo data expected Q4 2023.
- GADLEN platform: second NHP toxicology study showed inferior B-cell depletion; no IND planned until resolved.

## SEC filing metadata
- accession: 0001680367-23-000049
- form_type: 8-K
- ticker: STTK
- cik: 0001680367
- company_name: Shattuck Labs, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680367/000168036723000049/0001680367-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680367/000168036723000049/sttk-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001680367-23-000049
- JSON: https://secwatch.observer/filing/0001680367-23-000049.json
- Plain text: https://secwatch.observer/filing/0001680367-23-000049.txt

## Key facts
- Earnings Releases
  Shattuck Labs, Inc. reported financial results for quarter ended June 30, 2023.
  - Period: quarter ended June 30, 2023
  - Result: reported results
  source text: On August 10, 2023, Shattuck Labs, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680367/000168036723000049/0001680367-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.